Current Research Studies

SC-6020 SPEARHEAD-3: A Phase 1/2, Open-Label, Basket Study to Assess the Safety, Tolerability, and Anti-Tumor Activity of Afamitresgene Autoleucel in Pediatric Subjects with MAGE-A4 Positive Tumors

SC-6020 SPEARHEAD-3

  • Condition(s): Anus, Cervix, Bones and Joints, Kidney, Colon, Soft Tissue, Lung, Breast, Liver, Corpus Uteri, Esophagus, Eye and Orbit
  • Phase: Early Phase I
  • Clinicaltrials.gov ID: NCT05642455

What is the goal of the study?

SC-6020 SPEARHEAD-3 is a pediatric basket study to investigate the safety and efficacy of afamitresgene autoleucel in HLA-A*02 eligible and MAGE-A4 positive subjects aged 2-21 years of age with advanced cancers

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team: